Pharmaids Pharmaceuticals Limited

Equities

PHARMAID

INE117D01018

Pharmaceuticals

Delayed Bombay S.E. 03:00:41 2024-05-18 am EDT 5-day change 1st Jan Change
58.49 INR 0.00% Intraday chart for Pharmaids Pharmaceuticals Limited +11.90% +20.15%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Pharmaids Pharma Completes Acquisition of Adita Bio Sys MT
Pharmaids Pharmaceuticals Limited completed the acquisition of 99.86% stake in Adita Bio Sys Private Ltd. CI
Pharmaids Pharmaceuticals Limited announced that it has received INR 525.448343 million in funding from Asian Hotels Limited, Tumkur Trade Center Private Limited and another investors CI
Pharmaids Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Pharmaids Pharmaceuticals Names Chairman; Shares Slip 5% MT
Pharmaids Pharmaceuticals Buys Additional 1.25% Stake in Anugraha Chemicals MT
Pharmaids Pharmaceuticals Limited Appoints Shankarappa Nagaraja Vinaya Babu as Non-Executive Non-Independent Director and Chairman CI
Pharmaids Pharmaceuticals Limited agreed to acquire 99.86% stake in Adita Bio Sys Private Ltd. for INR 530 million. CI
Pharmaids Pharmaceuticals Limited Approves the Appointment of Dr. Prasad S as Chief Executive Officer CI
Pharmaids Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
Pharmaids Pharmaceuticals Limited Announces Board Changes CI
Pharmaids Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
Pharmaids Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023 CI
Pharmaids Pharmaceuticals Limited Announces Change in Registered Office Address CI
Pharmaids Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022 CI
Pharmaids Pharmaceuticals to Acquire Majority Stake in Anugraha Chemicals MT
Pharmaids Pharmaceuticals Limited Announces Vyasmurti Madhavrao Shingatgeri Resigned from the Post of Independent Director of the Company CI
Pharmaids Pharmaceuticals Approves Appointment of Pattamadai Natarajasarma Vijay as an Independent Director CI
Pharmaids Pharmaceuticals to Raise $2 Million via Equity Offering; Shares Jump 7% MT
Pharmaids Pharmaceuticals Limited Approves Resignation of Veerareddy Vallapureddy as Independent Director CI
Pharmaids Pharmaceuticals Limited announced that it expects to receive INR 168 million in funding CI
Pharmaids Pharmaceuticals Swings to Loss in Fiscal Q2 MT
Pharmaids Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022 CI
Pharmaids Pharmacuticals Appoints New CFO MT
Pharmaids Pharmaceuticals Names New CFO MT
Chart Pharmaids Pharmaceuticals Limited
More charts
Pharmaids Pharmaceuticals Limited is an India-based suppliers of a range of specialty chemicals, skin care, hospital care and generic products in the areas of orthopedic, neuro and gastro, and other. The Company is engaged in the business of trading and manufacturing of generics, bulk drugs and intermediaries, and other. The Company operates through a single segment, Drug Formulations. Its specialty chemicals products include Retino!, DL Alpha Tocopherol, D Pantothenate, Cyanocobalamin, Pyridoxine Hcl, Thiamine, Nicotinic Acid, Water Sol. Vitamin E, Coenzyme Q10 and D-Biotin. Its skin care products include Best care hands, Hands Sanitizer, Moisturizing Cream, Skinsure Plus, SkinSure Ultra, Alcohol Gel and Barrier Cream. Its hospital care products include Xepi Rub M, Facein Spray, Sod Hypochlorite, Sanmedin, Strumen G, Strumen TRIACID, Facein Eco, Facein Power 256, Facein Spray, Sod Hypochlorite, Wipes and PPE. Its generic products include Linzomust, Benfoshine, Amplimmune and other.
More about the company
  1. Stock Market
  2. Equities
  3. PHARMAID Stock
  4. News Pharmaids Pharmaceuticals Limited
  5. Pharmaids Pharmaceuticals Swings to Loss in Fiscal Q2
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW